Press-release for stocks

Prices are updated after-hours

crawled date : 2023 - 01 - 10 crawled time : 16:00

save search

NLS Pharmaceutics Announces Technology Patent Grant Covering Mazindol for Treatment of Attention Deficit Hyperactivity Disorder and Rare Sleep Disorders in Hong Kong
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
NLSP | $0.1496 4.29% 160K

| -90.35% | O: 2.58% H: 8.18% C: 6.92%
treatment rare patent grant technology

SOPHiA GENETICS and Leading US Cancer Center Collaborate to Combine Cancer Analysis Technology for Liquid Biopsies
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
SOPH | $4.85 -3.0% -3.09% 58K

| 123.21% | O: 7.14% H: 10.83% C: 6.67%
technology cancer

BrainStorm Cell Therapeutics Partners with NEALS, The ALS Association, and I AM ALS to Provide Public Access to Biospecimens from NurOwn's Phase 3 ALS Study
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
BCLI | $0.54 -7.53% -8.15% 570K

Health Technology

| -64.17% | O: -3.07% H: 5.06% C: 1.9%
als therapeutics study

Milestone Scientific Announces TEKMIKA as Exclusive STA Single Tooth Anesthesia System® Distributor in Brazil
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
MLSS | $0.58 -4.72% -0.97% 51K

Health Technology

| 16.79% | O: -0.23% H: 5.77% C: 0.23%
system brazil milestone

Solid Biosciences Outlines Strategy for Leadership in Precision Genetic Medicines with Focus on Neuromuscular and Cardiac Diseases
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
SLDB | $9.99 -3.66% -3.8% 150K

Health Technology

| 72.83% | O: 1.5% H: 0.16% C: -2.3%
genetic cardiac

Agenus to Participate at B Riley Securities’ 2023 Virtual Oncology Conference
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
AGEN 4 | $6.495 -20.31% -25.48% 1.5M

Health Technology

| 278.75% | O: 0.85% H: 10.88% C: 10.46%
conference

Cardiff Oncology to Present at B. Riley Securities' 3rd Annual Oncology Conference
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
CRDF | $5.265 -6.15% -6.55% 650K

Health Services

| 279.05% | O: 0.0% H: 2.19% C: 1.35%
conference

Qualigen Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for QN-302, a G-Quadruplex (G4) Transcription Inhibitor for the Intended Indication of Pancreatic Cancer
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
QLGN | $0.316 -4.82% -5.06% 36K

Health Technology

| -73.86% | O: 20.47% H: 3.92% C: -12.42%
qn-302 designation drug therapeutics food cancer pancreatic

Biomerica Appoints Mayo Clinic Gastroenterologist, Dr. Brian E. Lacy, to the Company’s Scientific Advisory Board
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
BMRA | $0.795 -3.99% -4.15% 130K

Health Technology

| -75.65% | O: 1.76% H: 2.31% C: 2.31%

BIOLASE INC. ANNOUNCES PRICING OF APPROXIMATELY $9.75 MILLION UNDERWRITTEN PUBLIC OFFERING
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
BIOL | $0.1375 -3.03% -3.13% 1.2M

Health Technology

| -79.52% | O: -46.55% H: 32.43% C: 3.0%
offering

Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
EVO | $7.32 2.38% 2.32% 36K

Manufacturing

| -15.23% | O: 0.81% H: 3.34% C: 0.92%
SEOVF | $0.335 15.67% 15K

Health Technology

| -52.82% | O: -0.86% H: 0.0% C: -0.55%
diabetes potential

Sixth Wave Innovations Inc. expands their Valuable IP portfolio adding two ‘MIP’ patents for the Unique IXOS Metals Extraction and Purification System
Published: 2023-01-10 (Crawled : 16:00) - sixthwave.com
SIXWF | $0.01 900.0% 18K

n/a

| -94.9% | O: -10.71% H: 0.0% C: -10.0%
ixos system unique

NTT DATA Business Solutions Partners with Aviatrix for Business-Critical Cloud Networking Infrastructure
Published: 2023-01-10 (Crawled : 16:00) - prnewswire.com
SAPGF | $182.094 -19.46% 16K

Technology Services

| 62.58% | O: 0.63% H: 0.27% C: 0.14%
SAP | $180.23 -0.3% 0.0% 530K

Technology Services

| 62.22% | O: 0.78% H: 1.0% C: 0.99%
solutions cloud

REV GROUP PUBLISHES 2022 CORPORATE SUSTAINABILITY REPORT
Published: 2023-01-10 (Crawled : 16:00) - revgroup.com
REVG | $22.1 -1.6% 0.0% 680K

Consumer Durables

| 69.89% | O: 0.0% H: 1.8% C: 0.76%
report group

Foundation Medicine Announces Collaboration with Karyopharm Therapeutics to Develop FoundationOne®CDx as a Companion Diagnostic for XPOVIO® (selinexor)
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
KPTI | $1.155 -5.33% -5.63% 810K

Health Technology

| -57.04% | O: -0.35% H: 3.18% C: 1.41%
foundationone collaboration diagnostic therapeutics

BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
TECH | $65.51 -1.83% -1.86% 730K

Health Technology

| -20.5% | O: 1.02% H: 2.28% C: 2.05%
plus therapy

Kymera Therapeutics Shares Key 2023 Goals to Support its Evolution into a Fully Integrated Degrader Medicines Company
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
SNY | $46.22 0.63% 0.63% 1.7M

Health Technology

| -5.53% | O: -0.49% H: 0.0% C: 0.0%
KYMR | $34.4 -3.32% -3.43% 530K

Health Technology

| 31.63% | O: 0.78% H: 9.65% C: 8.3%
therapeutics

Inari Medical Announces Preliminary 2022 Revenue and 2023 Guidance
Published: 2023-01-10 (Crawled : 16:00) - biospace.com/
NARI | $39.48 -3.19% -3.29% 1.2M

Health Technology

| -36.28% | O: 10.57% H: 0.85% C: -4.53%
medical